TWD 52.7
(0.38%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 109.42 Million | 377.9 Million | -229.78 Million | -28.72 Million | - |
Net Income | 36.09 Million | 162.92 Million | 537.79 Million | 46.23 Million | - |
Depreciation & Amortization | 54.11 Million | 33.28 Million | 37.74 Million | 4.61 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 30.1 Million | 302.71 Million | -794.19 Million | -77.29 Million | - |
Other non-cash items | 1.56 Million | 6.74 Million | 9.79 Million | -2.14 Million | - |
Investing Cash Flow | -61.31 Million | 29.55 Million | -212.94 Million | -262.5 Million | - |
Investments in PPE | -34.43 Million | -21.16 Million | -126.8 Million | -261.51 Million | - |
Acquisitions | 5.97 Million | - | - | - | 15.18 Million |
Investment purchases | -45.96 Million | -21 Thousand | -78.84 Million | -922 Thousand | - |
Sales/Maturities of investments | 5.46 Million | 42.68 Million | - | -922 Thousand | - |
Other Investing Activities | -4.92 Million | 3.16 Million | -9.67 Million | -1.36 Million | - |
Financing Cash Flow | -81.43 Million | -513.69 Million | 598.82 Million | 346.37 Million | - |
Debt repayment | -163.07 Million | -297.27 Million | -998.23 Million | -71.2 Million | - |
Dividends payments | -135.32 Million | -210.14 Million | -128.64 Million | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | 222.83 Million | - | - | 276.27 Million | - |
Other Financing Activities | -5.86 Million | - | -254.86 Million | - | - |
Accounts receivables | -72.61 Million | - | - | - | - |
Accounts payables | 58.49 Million | - | - | - | - |
Inventory | 49.16 Million | -46.19 Million | -24.91 Million | 2.84 Million | - |
Other working capital | 53.55 Million | - | - | - | - |
Cash at beginning of period | 399.87 Million | 481.98 Million | 324.31 Million | 64.19 Million | - |
Cash at end of period | 350.09 Million | 399.87 Million | 481.98 Million | 112.6 Million | - |
Capital Expenditure | -34.43 Million | -21.16 Million | -126.8 Million | -261.51 Million | - |
Effect of forex changes on cash | -16.45 Million | 24.12 Million | 1.57 Million | -6.74 Million | - |
Net cash flow / Change in cash | -49.77 Million | -82.11 Million | 157.67 Million | 48.4 Million | - |
Free Cash Flow | 74.98 Million | 356.73 Million | -356.59 Million | -290.24 Million | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -39.58 Million | -3.42 Million | 36.09 Million | -15.31 Million | 42.33 Million | 43.78 Million |
Depreciation & Amortization | 19.4 Million | 18.99 Million | 54.11 Million | 13.22 Million | 13.6 Million | 13.62 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 67.6 Million | -36.45 Million | 30.1 Million | 92.71 Million | 49.7 Million | -116.75 Million |
Other non-cash items | 3.91 Million | 3.04 Million | 1.56 Million | -421 Thousand | 2.14 Million | 436 Thousand |
Investing Cash Flow | 49.47 Million | -40.15 Million | -61.31 Million | -11.18 Million | -66.15 Million | -583 Thousand |
Investments in PPE | -21.19 Million | -32.21 Million | -34.43 Million | -18.88 Million | -4.16 Million | -9.58 Million |
Acquisitions | 1.22 Million | - | - | - | - | - |
Investment purchases | 8.26 Million | -8.31 Million | -45.96 Million | -1.54 Million | -44.42 Million | - |
Sales/Maturities of investments | 60.21 Million | - | 5.46 Million | 46 Thousand | -15.15 Million | 5.08 Million |
Other Investing Activities | -1.93 Million | -2.18 Million | -4.92 Million | 340 Thousand | -5.48 Million | 260 Thousand |
Financing Cash Flow | -56.01 Million | -3.05 Million | -81.43 Million | -4.34 Million | -27.22 Million | -78.16 Million |
Debt repayment | -50.43 Million | -2.15 Million | -163.07 Million | -67.77 Million | -183.98 Million | -76.76 Million |
Dividends payments | - | - | -135.32 Million | -70.66 Million | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 222.83 Million | - | - | - |
Other Financing Activities | -5.57 Million | - | - | - | - | - |
Accounts receivables | 68.52 Million | - | - | - | - | - |
Accounts payables | 95.28 Million | - | - | - | - | - |
Inventory | -107.79 Million | 71.72 Million | 49.16 Million | -7.81 Million | 50.22 Million | 51.74 Million |
Other working capital | 11.59 Million | - | - | - | - | - |
Cash at beginning of period | 301.27 Million | 350.09 Million | 399.87 Million | 292.29 Million | 268.28 Million | 422.66 Million |
Cash at end of period | 334.52 Million | 301.27 Million | 350.09 Million | 350.09 Million | 292.29 Million | 268.28 Million |
Capital Expenditure | -21.19 Million | -32.21 Million | -34.43 Million | -18.88 Million | -4.16 Million | -9.58 Million |
Effect of forex changes on cash | 9.16 Million | 5.57 Million | -16.45 Million | -14.69 Million | 8.77 Million | -10.35 Million |
Net cash flow / Change in cash | 33.25 Million | -48.82 Million | -49.77 Million | 57.79 Million | 24.01 Million | -154.37 Million |
Free Cash Flow | 9.42 Million | -43.4 Million | 74.98 Million | 69.14 Million | 104.45 Million | -74.85 Million |
ADWPF
QBIO
TNXT
BOIRF
NUR
603726